Damodaran, S., Damaschke, N., Gawdzik, J., Yang, B., Shi, C., Allen, G. O., . . . Jarrard, D. (2017). Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes. BMC Cancer.
Styl ChicagoDamodaran, Shivashankar, Nathan Damaschke, Joseph Gawdzik, Bing Yang, Cedric Shi, Glenn O. Allen, Wei Huang, John Denu, a David Jarrard. "Dysregulation of Sirtuin 2 (SIRT2) and Histone H3K18 Acetylation Pathways Associates With Adverse Prostate Cancer Outcomes." BMC Cancer 2017.
Citace podle MLADamodaran, Shivashankar, et al. "Dysregulation of Sirtuin 2 (SIRT2) and Histone H3K18 Acetylation Pathways Associates With Adverse Prostate Cancer Outcomes." BMC Cancer 2017.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..